The study, which compares data from the mammography programme with that from the National Cancer Register, confirms the effectiveness of the mammography programme in detecting cancers at an early stage. Photo: Shutterstock

The study, which compares data from the mammography programme with that from the National Cancer Register, confirms the effectiveness of the mammography programme in detecting cancers at an early stage. Photo: Shutterstock

The department of health and the Epican cancer epidemiology and prevention group at the Luxembourg Institute of Health (LIH) on Monday 20 January jointly published a report on the evaluation of the "mammography programme" (PM), the national organised breast cancer screening programme. Here are the main findings.

Every year, between 400 and 450 new cases of breast cancer are diagnosed in Luxembourg, according to the National Health Laboratory. The new report on the evaluation of the “mammography programme” (PM)--the breast cancer screening programme organised on a national level--published on Monday 20 January jointly by the health department and the Epican cancer epidemiology and prevention group at the Luxembourg Institute of Health (LIH), reveals major advances in the early detection of this disease.

For the first time, data from the mammography programme has been cross-referenced with that from the National Cancer Register (RNC), using a methodology developed by Epican. “With this new methodology, Luxembourg joins a small group of European countries able to assess the effectiveness of breast cancer screening at such a high level,” explained the RNC’s scientific director and head of the study, Dr Claudine Backes. "We hope that the results of this report will be used to guide public health actions and future evaluations in order to detect breast cancer as early as possible in Luxembourg."

The examinations confirm the effectiveness of PM, particularly in detecting cancers at early stages. Analyses show that tumours detected through the programme are often smaller, localised, without metastases and with fewer cases of lymph node invasion, leading to less extensive treatment and a better chance of remission.

One of the strengths of the programme lies in the double reading of mammograms, where each examination is analysed by two independent radiologists. This process makes it possible to detect one breast cancer in five that would have been missed with a single reading. It also reduces the number of false positives and the need for additional tests, thereby cutting costs and reducing stress for participants, according to the study.

Insufficient participation

The report nevertheless points out that, despite the quality of its organisation, the participation rate in screening still leaves something to be desired. Between 2011 and 2018, although it was higher than in neighbouring countries, it still fell short of European recommendations. Analysis of the data also showed that the participation rate has fallen steadily in recent years, without the institutions being able to explain the reasons for this.

“This report marks an important step in our efforts to improve the health and well-being of women in Luxembourg,” concluded the minister for health and social security, Martine DeprezMartine Deprez (CSV). The health ministry also pointed out that since 1 July 2024, the age of access to the screening programme has been extended. From now on, all women between the ages of 45 and 74 and affiliated with the CNS can benefit from the programme.

This article was originally published in French.